Tommi Lehtonen

Tommi Lehtonen

Vorstandsvorsitzender bei Blueprint Genetics Oy

54 Jahre
Commercial Services
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Tommi Lehtonen

EinheitArt der EinheitIndustrie
14
Subsidiary Biotechnology 14
4
Holding Company Packaged Software 4

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Tommi Lehtonen

UnternehmenSektorVerknüpfte PersonenHauptposition
AFFYMETRIX, INC. Medical Specialties

Gary Zweiger

Corporate Officer/Principal

AGILENT TECHNOLOGIES, INC. Miscellaneous Commercial Services

Gary Zweiger

Corporate Officer/Principal

Miscellaneous Commercial Services

Samuel Myllykangas

Founder

Internet Software/Services

Adam Ghobarah

Director/Board Member

Medical Specialties

Hilde Furberg

Corporate Officer/Principal

Financial Conglomerates

Hilde Furberg

Director/Board Member

PCI BIOTECH HOLDING ASA Biotechnology

Hilde Furberg

Director/Board Member

Medical/Nursing Services

Gary Zweiger

Consultant / Advisor

Stanford University College/University

Gary Zweiger

Doctorate Degree

Investment Managers

David Germonpré

Private Equity Investor

The University of Texas at Austin College/University

Adam Ghobarah

Doctorate Degree

CALLIDITAS THERAPEUTICS AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

University of Turku College/University

Juha Koskenvuo

Doctorate Degree

WEIFA ASA Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

University of Oslo College/University

Hilde Furberg

Graduate Degree

University of Helsinki College/University

Tuomas Ristonpoika Kosonen

Ville Samuel Koskenvuo

Samuel Myllykangas

Undergraduate Degree

Graduate Degree

Doctorate Degree

Medical Specialties

Erik Jan Zimmer

Chief Operating Officer

MBA Institute College/University

Erik Jan Zimmer

Undergraduate Degree

BIONANO GENOMICS, INC. Biotechnology

Gary Zweiger

Corporate Officer/Principal

Pharmaceuticals: Major

Hilde Furberg

Corporate Officer/Principal

Medical Specialties

Gary Zweiger

Corporate Officer/Principal

Investment Managers

Adam Ghobarah

Private Equity Investor

Baxter Medical AB

Hilde Furberg

Corporate Officer/Principal

BERGENBIO ASA Pharmaceuticals: Major

Hilde Furberg

Chairman

Investment Managers

Risto Sakari Kankaanpää

Private Equity Investor

HERANTIS PHARMA OYJ Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

COMBIGENE AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

Investment Managers

Gary Zweiger

Private Equity Investor

Electronic Production Equipment

David Germonpré

Director/Board Member

Industrial Machinery

David Germonpré

Director/Board Member

Investment Managers

David Germonpré

Private Equity Investor

SEDANA MEDICAL AB Medical Specialties

Hilde Furberg

Director/Board Member

CONVATEC GROUP PLC Medical Specialties

Erik Jan Zimmer

Corporate Officer/Principal

Miscellaneous Commercial Services

Hilde Furberg

Director/Board Member

Packaged Software

David Germonpré

Director/Board Member

Financial Conglomerates

Gary Zweiger

Founder

Biotechnology

Hilde Furberg

Director/Board Member

Real Estate Development

Hilde Furberg

Corporate Officer/Principal

Internet Software/Services

Adam Ghobarah

Director/Board Member

Tappin AS

Hilde Furberg

Director/Board Member

Miscellaneous Commercial Services

Gary Zweiger

Founder

ONCOZENGE AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

Computer Processing Hardware

Risto Sakari Kankaanpää

Chief Executive Officer

Information Technology Services

Tero-Pekka Alastalo

President

Investment Managers

Adam Ghobarah

Founder

Statistik

International

Vereinigte Staaten 19
Norwegen 11
Finnland 7
Schweden 6
Belgien 5

Sektoral

Health Technology 20
Finance 10
Consumer Services 7
Commercial Services 5
Technology Services 5

Operativ

Director/Board Member 67
Corporate Officer/Principal 21
Chairman 14
Independent Dir/Board Member 10
Private Equity Investor 10
  1. Börse
  2. Insiders
  3. Tommi Lehtonen
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT